Banque Transatlantique SA Takes Position in KKR & Co. Inc. (NYSE:KKR)

Banque Transatlantique SA purchased a new stake in shares of KKR & Co. Inc. (NYSE:KKR - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm purchased 84,884 shares of the asset manager's stock, valued at approximately $12,555,000.

A number of other institutional investors have also recently made changes to their positions in the stock. Banque de Luxembourg S.A. bought a new position in KKR & Co. Inc. during the fourth quarter valued at approximately $288,000. Bayesian Capital Management LP raised its stake in KKR & Co. Inc. by 106.4% during the 4th quarter. Bayesian Capital Management LP now owns 14,163 shares of the asset manager's stock valued at $2,095,000 after buying an additional 7,300 shares during the last quarter. Bearing Point Capital LLC bought a new position in shares of KKR & Co. Inc. during the 4th quarter valued at $4,342,000. Benjamin Edwards Inc. boosted its stake in shares of KKR & Co. Inc. by 32.0% in the 4th quarter. Benjamin Edwards Inc. now owns 5,444 shares of the asset manager's stock worth $805,000 after buying an additional 1,321 shares during the last quarter. Finally, AXA S.A. grew its holdings in shares of KKR & Co. Inc. by 196.0% in the fourth quarter. AXA S.A. now owns 88,800 shares of the asset manager's stock worth $13,134,000 after acquiring an additional 58,801 shares during the period. Hedge funds and other institutional investors own 76.26% of the company's stock.

KKR & Co. Inc. Trading Down 0.4 %

KKR traded down $0.50 during trading on Friday, hitting $118.23. 2,783,772 shares of the stock were exchanged, compared to its average volume of 4,998,063. The company has a debt-to-equity ratio of 0.82, a quick ratio of 0.07 and a current ratio of 0.07. The firm has a 50 day simple moving average of $111.09 and a 200 day simple moving average of $136.31. The firm has a market cap of $105.02 billion, a price-to-earnings ratio of 35.50, a P/E/G ratio of 1.00 and a beta of 1.91. KKR & Co. Inc. has a 1 year low of $86.15 and a 1 year high of $170.40.

KKR & Co. Inc. (NYSE:KKR - Get Free Report) last announced its quarterly earnings results on Thursday, May 1st. The asset manager reported $1.15 EPS for the quarter, beating the consensus estimate of $1.13 by $0.02. The firm had revenue of $1.77 billion for the quarter, compared to analyst estimates of $1.71 billion. KKR & Co. Inc. had a return on equity of 6.20% and a net margin of 14.31%. The business's revenue for the quarter was down 67.8% on a year-over-year basis. During the same quarter last year, the firm posted $0.97 earnings per share. As a group, equities analysts expect that KKR & Co. Inc. will post 5.19 EPS for the current year.

KKR & Co. Inc. Increases Dividend

The firm also recently declared a dividend, which will be paid on Tuesday, May 27th. Stockholders of record on Tuesday, May 13th will be issued a $0.185 dividend. The ex-dividend date of this dividend is Monday, May 12th. This represents a dividend yield of 0.64%. This is a positive change from KKR & Co. Inc.'s previous dividend of $0.17. KKR & Co. Inc.'s payout ratio is currently 31.22%.

Wall Street Analysts Forecast Growth

Several brokerages have issued reports on KKR. Morgan Stanley raised their target price on KKR & Co. Inc. from $114.00 to $120.00 and gave the stock an "equal weight" rating in a research report on Monday. HSBC upgraded shares of KKR & Co. Inc. from a "hold" rating to a "buy" rating and cut their target price for the company from $170.00 to $119.00 in a research report on Tuesday, April 15th. Bank of America dropped their price target on shares of KKR & Co. Inc. from $214.00 to $194.00 and set a "buy" rating on the stock in a research note on Friday, April 4th. TD Cowen reduced their price objective on KKR & Co. Inc. from $183.00 to $126.00 and set a "buy" rating for the company in a research note on Wednesday, April 9th. Finally, Barclays raised their target price on KKR & Co. Inc. from $129.00 to $141.00 and gave the stock an "overweight" rating in a report on Friday, May 2nd. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating, fourteen have given a buy rating and two have assigned a strong buy rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and an average price target of $144.73.

Insider Transactions at KKR & Co. Inc.

In related news, Director Robert W. Scully bought 13,250 shares of the business's stock in a transaction on Tuesday, May 6th. The shares were bought at an average price of $113.49 per share, for a total transaction of $1,503,742.50. Following the completion of the purchase, the director now directly owns 13,250 shares of the company's stock, valued at approximately $1,503,742.50. This trade represents a ∞ increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, major shareholder Genetic Disorder L.P. Kkr sold 6,000,000 shares of the stock in a transaction dated Wednesday, March 5th. The shares were sold at an average price of $32.96, for a total transaction of $197,760,000.00. Following the sale, the insider now directly owns 19,260,971 shares of the company's stock, valued at approximately $634,841,604.16. The trade was a 23.75 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 39.34% of the company's stock.

KKR & Co. Inc. Company Profile

KKR & Co, Inc operates as an investment firm. It offers alternative asset management as well as capital markets and insurance solutions. The firm's business segments include Asset Management and Insurance Business. The Asset Management segment engages in providing private equity, real assets, credit and liquid strategies, capital markets, and principal activities.